IRIDEX CFO Buys 5,004 Shares as Q1 Loss Narrows to $0.03
IRIX•IRIDEX CFO Dizon Romeo R increased his stake by buying 5,004 shares, bringing his total to 126,004 shares. Q1 2026 net loss narrowed to $0.03 per share from $0.10 year-over-year, as revenue fell 1% to $11.8 million, contracting gross margin to 40% from 43%.
1. Insider Purchase Details
CFO Dizon Romeo R purchased 5,004 shares at $1.00 each, increasing his holdings to 126,004 shares, reflecting strong insider confidence in the company’s outlook.
2. Q1 Financial Results
IRIDEX posted a net loss of $0.03 per share in the first quarter of 2026, a marked improvement from a $0.10 loss in the prior year period, supported by a 4% reduction in operating expenses to $5.1 million.
3. Revenue and Margin Trends
Total revenue dipped 1% to $11.8 million, driven by weaker retina product sales and ongoing supply-chain challenges, which compressed gross margin from 43% to 40%.
4. Product Line Performance
Glaucoma product revenue rose 14% to $3.6 million on stronger Cyclo G6 probe sales, while retina product revenue declined to $5.8 million from $6.6 million year-over-year.
